Navigation thread
Unit of Cancer immunotherapy
Research - Unit of Cancer immunotherapy
The research of the unit is carried out through the following IDIBAPs research groups:
Lines of research
- Therapy with chimeric antigen receptor (CAR) T-cells
- Therapy with tumour-infiltrating lymphocytes (TILs)
- Combinations of adoptive cell immunotherapy with other drugs or strategies (anti-PD-1/PD-L1 antibodies, bispecific antibodies, radiotherapy, etc.)
- Other advanced therapies for cancer treatment